The University of South Alabama is a public research university in Mobile, Alabama. It was created by the Alabama Legislature in May, 1963, and replaced existing extension programs operated in Mobile by the University of Alabama.

During the past decade, University of South Alabama conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 29 clinical trials were completed, i.e. on average, 85.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Alabama" #1 sponsor was "SWOG Cancer Research Network" with 19 trials, followed by "Radiation Therapy Oncology Group" with 9 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials sponsored, "University of South Alabama" with 7 trials sponsored and "Children's Oncology Group" with 7 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Alabama" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 97 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "University of South Alabama" are "HIV Infections" (11 trials), "Breast Cancer" (8 trials), "Pulmonary Arterial Hypertension" (6 trials), "Head and Neck Cancer" (5 trials) and "Lung Cancer" (5 trials). Many other conditions were trialed in "University of South Alabama" in a lesser frequency.

Most popular intervention types in "University of South Alabama" are "Drug" (95 trials), "Radiation" (18 trials), "Biological" (16 trials), "Other" (13 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "cyclophosphamide" (12 trials), "doxorubicin hydrochloride" (10 trials), "etoposide" (7 trials) and "filgrastim" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of South Alabama" are 110 trials for "All" genders, 21 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "University of South Alabama". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 97 completed trials in University of South Alabama, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Alabama, 4 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 13 trials that are defined as “Not Applicable".

University of South Alabama has several departments that took part in Clinical trials: "University of South Alabama Cancer Research Institute" - 19 trials, "University of South Alabama Department of Neurology" - 3 trials, "University of South Alabama Department of Surgery" - 2 trials